Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Rick Admiraal

Clinical research fellow pediatric oncology
-
  • Improved survival with model-based dosing of antithymocyte globulin in pediatric hematopoietic cell transplantation

    • mei 2025
    • Rick, Admiraal, et al
    • Blood advances
  • A practical guide to therapeutic drug monitoring in busulfan

    • dec. 2024
    • Vera, Domingos, et al
    • Bone Marrow Transplantation
  • Effect of clofarabine and fludarabine exposure on outcome after pediatric allogeneic hematopoietic cell transplantation

    • sep. 2024
    • Linde, Dekker, et al
    • Blood neoplasia
  • High-dose individualized antithymocyte globulin with therapeutic drug monitoring in high-risk cord blood transplant

    • jan. 2024
    • Rick, Admiraal, et al
    • Cytotherapy
  • Anti-thymocyte globulin exposure in patients with diffuse cutaneous systemic sclerosis undergoing autologous haematopoietic stem cell transplantation

    • okt. 2023
    • Yu-Hsiang, Chiu, et al
    • Journal of scleroderma and related disorders
View all publications